PLEASE REVIEW OUR PRIVACY & COOKIES NOTICE

We use cookies to collect and analyze information on site performance and usage and to ensure you can successfully navigate throughout the site. By clicking the “ACCEPT” button to your right or by clicking on any site content, you agree to the placement of cookies on your computer. For more information, see our Privacy Policy.

 
Locations
 
WEBSITES
  • United States (English)
  • International (English)
  • Chinese (中文)
  • French (Français)
  • German (Deutsch)
  • Italian (Italiano)
  • Japanese (日本語)
  • Russian (Русский)
 

Leaving U.S. website

You are now leaving the Haemonetics U.S. website, click 'Yes' to continue or 'No' to stay on the U.S. website.

YesNo
  • Investor Relations
  • LOGIN
    • Haemonetics
    • HSS Client Login
    • Software Download Center
  • REGISTER
  • Home
  • Products
     
    U.S. ProductsView International Products
    Devices
    Blood Center Devices
    • ACP 215
    • MCS+ 8150
    • MCS+ 9000
    • NexSys PCS
    • PCS 2
    Plasma Center Devices
    • NexSys PCS with Persona Technology
    • NexSys PCS with YES Technology
    • NexSys PCS
    • PCS 2
    Surgical and Diagnostic Devices
    • Cell Saver Elite+
    • Cell Saver 5+
    • Cell Saver Elite
    • TEG
    Software
    Hospital Software
    • BloodTrack
    • SafeTrace Tx
    Plasma Center Software
    • DMS
    • NexLynk DMS
    • NextGen
    Services
    Consulting Services
    • Process Improvement
     
  • Solutions
     
    Blood Management Solutions
    • Solutions for Blood Centers
    • Solutions for Hospitals
    • Solutions for Plasma Centers
     
  • Learning Center
     
    Product Training
    • All Products
    • Blood Centers
    • Hospitals
    • Plasma Centers
    Thought Leadership
    • White Papers & Clinical Reviews
    • Reference Lists
    • Poster Abstracts
    Education
       
    • About Haemonetics
       
      Company Background
      • Overview
      • Historical Timeline
      • Leadership Team
      • Scientific Advisory Council

      • Office Locations
      Investor Relations
      • Investor Relations Home
      • Stock Information
      • Earnings
      • Forecasts & Guidance
      Corporate Responsibility
      • Corporate Responsibility at Haemonetics
      Donors Make It Matter
      • Donors Make It Matter Campaign
      News & Events
      • In the News
      • Calendar of Events
      • Publications
      Careers
      • Careers Overview
      • Open Positions
      • Our Global HQ

      Grants

      • Grant Program

       
    • Customer Support

    Leaving U.S. website

    You are now leaving the Haemonetics U.S. website, click 'Yes' to continue or 'No' to stay on the U.S. website.

    YesNo
    • Home
    • Learning Center
    • Thought Leadership
    • White Papers & Clinical Reviews
    • Contact Us
    • Print
    • Share

    White Papers & Clinical Reviews

    • FOCUS Trial
    • FOCUS Trial - Functional outcomes in cardiovascular patients undergoing surgical repair of hip fracture

      Clinical Review: N Engl J Med 2011; 365:2453-62

      Conclusion: A liberal transfusion strategy, as compared with a restrictive strategy, did not reduce rates of death or inability to walk independently on 60-day follow-up or reduce in-hospital morbidity in elderly patients at high cardiovascular risk.
      View document
    • Anemia and the Perioperative Patient

      White Paper by M. Popovsky, M.D., R. Thurer, M.D., P. Parce, RN

      Excerpt: Anemia is a remarkably prevalent condition. Forty percent of patients presenting with hip fracture and 38% of acutely admitted geriatric patients have anemia (5). Studies of critically ill patients found that 77% experience anemia in the ICU. Sixty three percent of these patients had hemoglobin values less than 12 g/dL and 29% less than 10g/dL. View document View reference list
    • Blood Management: State of the Art
      The Use of Red Blood Cells and Fresh Frozen Plasma

      White Paper by M. Popovsky, M.D., R. Thurer, M.D., P. Parce, RN

      Excerpt: Blood transfusion is an integral part of medical and surgical practice, and its safety is now assumed. Although the transmission of virus-borne diseases – such as HIV and hepatitis – by blood transfusion are extraordinarily rare events, blood should be viewed as a potent drug that entails significant risk.
      View document View reference list
    • The Pros and Cons of Preoperative Autologous Blood Donation

      White Paper by Mark A. Popovsky, M.D., Robert L. Thurer, M.D.

      Preoperative autologous blood donation (PABD) was once a powerful tool to decrease the risk of transfusion-transmitted disease related to allogeneic blood. With the development of effective viral screening tests and the recognition of the many disadvantages of stored blood, the need for and appropriateness of PABD has greatly diminished. There are now better and safer alternatives. The advantages and disadvantages of PABD are discussed in this review. View document
    • Contact Us
    • Terms of Use
    • Quality
    • Careers
    • Privacy Policy
    • Site Map

    © 2011-2020 Haemonetics Corporation